- Home
- TNON vs ATNF Comparison
TNON vs ATNF Comparison
Compare TNON & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- ATNF
- Stock Information
- Founded
- TNON 2012
- ATNF 2016
- Country
- TNON United States
- ATNF United States
- Employees
- TNON N/A
- ATNF N/A
- Industry
- TNON Medical Specialities
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- ATNF Health Care
- Exchange
- TNON Nasdaq
- ATNF Nasdaq
- Market Cap
- TNON 6.7M
- ATNF 5.7M
- IPO Year
- TNON 2022
- ATNF N/A
- Fundamental
- Price
- TNON $1.79
- ATNF $1.56
- Analyst Decision
- TNON Strong Buy
- ATNF
- Analyst Count
- TNON 2
- ATNF 0
- Target Price
- TNON $16.00
- ATNF N/A
- AVG Volume (30 Days)
- TNON 153.6K
- ATNF 1.1M
- Earning Date
- TNON 03-11-2025
- ATNF 02-13-2025
- Dividend Yield
- TNON N/A
- ATNF N/A
- EPS Growth
- TNON N/A
- ATNF N/A
- EPS
- TNON N/A
- ATNF N/A
- Revenue
- TNON $3,315,000.00
- ATNF N/A
- Revenue This Year
- TNON $29.03
- ATNF N/A
- Revenue Next Year
- TNON $100.29
- ATNF $54.15
- P/E Ratio
- TNON N/A
- ATNF N/A
- Revenue Growth
- TNON 38.30
- ATNF N/A
- 52 Week Low
- TNON $1.65
- ATNF $1.16
- 52 Week High
- TNON $15.79
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- TNON 39.49
- ATNF 40.40
- Support Level
- TNON $1.65
- ATNF $1.40
- Resistance Level
- TNON $2.30
- ATNF $1.67
- Average True Range (ATR)
- TNON 0.16
- ATNF 0.19
- MACD
- TNON 0.01
- ATNF -0.00
- Stochastic Oscillator
- TNON 21.57
- ATNF 13.22
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.